Frequently Asked Questions CJC-1295 is a synthetic analogue of growth hormone releasing hormone (GHRH) that stimulates the pituitary gland to increase growth hormone secretion
References : All statements above are supported by cited sources, including the FDA warning letter ( [2] ) ( [15] ), industry analyses ( [1] ) ( [3] ), and research publications ( [16] ) ( [4] ), among others
Palladino AA, Sayed S, Levitt Katz LE, Gallagher PR, De Leon DD
Supplied at 10mg per vial by Pinnacle Peptides
However, unlike the non-cleavable probe, the cell-impermeant reducing agent Mesna can be used to un-label residual surface receptors, as previously described using non-lanthanide SNAP-probes (Buenaventura et al., 2018), so that fluorescent signal originates exclusively from internal receptors endocytosed during a prior agonist treatment step (see Supplementary Figure 2E, 2F for optimisation of Mesna cleavage)
November 18, 2025